PassFinals
Musculoskeletal

Enteropathic arthritis

Axial or peripheral spondyloarthritis associated with Crohn’s disease or ulcerative colitis, requiring coordinated gastroenterology and rheumatology care.

In a nutshell

Enteropathic arthritis is axial or peripheral spondyloarthritis associated with Crohn’s disease or ulcerative colitis. Peripheral and bowel activity may correlate, but axial disease can be independent, so treatment must be coordinated across gastroenterology and rheumatology.

Classic presentation

Asymmetric lower-limb arthritis, enthesitis or inflammatory back pain in a patient with inflammatory bowel disease, with activity that may or may not match bowel symptoms.

Key points

  • It is part of the spondyloarthritis family, with peripheral arthritis, enthesitis, dactylitis or axial disease.
  • Peripheral joint symptoms may track bowel activity; axial disease can run independently.
  • A hot joint still requires urgent exclusion of septic arthritis or crystals.
  • Use caution with NSAIDs and follow current BNF and specialist advice in inflammatory bowel disease.
  • Biologic or targeted therapy must be chosen for both the bowel and the joints.
  • Same-day ophthalmology is required for a painful red eye with photophobia or blurred vision.

First-line investigation

Assess bowel and joint activity together; use inflammatory markers, joint aspiration for acute monoarthritis, IBD investigations when indicated, and axial imaging when inflammatory back pain is present.

Management

Coordinate the two disease pathways

  • Assess bowel activity, joint pattern, function, infection risk and extra-articular disease with gastroenterology and rheumatology input.1,2,3

Exclude joint infection

  • Aspirate an acute hot joint before attributing it to enteropathic arthritis or escalating immunosuppression.5,1

Treat bowel and joint inflammation safely

  • Use the appropriate IBD pathway, cautious symptom control and local treatment; review NSAID risks and check BNF advice.2,3,1,4

Choose therapy for both organs

  • For persistent disease, select DMARD or targeted therapy with gastroenterology and rheumatology so the chosen agent suits bowel phenotype and joint pattern.1,2,3,4

Monitor activity, safety and complications

  • Review bowel and joint control, infection, bone health, treatment toxicity and uveitis symptoms; reassess promptly when the two organs behave discordantly.1,2,3

Exam traps

  • Axial disease may remain active when bowel symptoms are controlled.
  • Do not assume a hot joint is an inflammatory flare; exclude infection and crystals.
  • Not every biologic used in spondyloarthritis or psoriasis is suitable for inflammatory bowel disease.
  • Normal inflammatory markers do not exclude enteropathic arthritis.

Illustrations

Active sacroiliitis on MRISemicoronal sacroiliac-joint MRI showing inflammatory marrow signal adjacent to the sacroiliac joint, illustrating axial spondyloarthritis that can accompany inflammatory bowel disease.Fiona McQueen, Marissa Lassere and Mikkel Østergaard, Wikimedia Commons · CC-BY-2.0

Key sources

  1. NICE NG65: Spondyloarthritis in over 16s: diagnosis and management (UK referral, imaging, axial and peripheral spondyloarthritis management and extra-articular care.)Updated 4 Mar 2025
  2. NICE NG129: Crohn’s disease: management (Current NICE management pathway for Crohn’s disease, including biologic review and specialist treatment.)
  3. NICE NG130: Ulcerative colitis: management (Current NICE management pathway for ulcerative colitis and severe flares.)
  4. BNF online (Check current NSAID, DMARD and biologic prescribing, interactions, contraindications and monitoring.)
  5. NHS: Reactive arthritis (UK information supporting urgent assessment of a hot joint and inflammatory arthritis differentials.)Updated 16 Dec 2024

This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.